NCT05714826

Brief Summary

The proposed study is aimed at a comprehensive optimization at-time of radical cystectomy (COARC) intervention that focuses on patient optimization throughout the perioperative continuum, from the pre-operative setting to the post-operative period, among patients undergoing radical cystectomy for bladder cancer. This multi-modal strategy will focus on three phases of care around surgery: the pre-operative, peri-operative, and post-operative phases. The intervention group will focus on multiple areas of patient optimization including remote patient monitoring for the earlier identification of potential complications. The overall study mission is to decrease complication rates after radical cystectomy using this comprehensive approach.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
194

participants targeted

Target at P75+ for not_applicable

Timeline
3mo left

Started Apr 2024

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress87%
Apr 2024Aug 2026

First Submitted

Initial submission to the registry

January 26, 2023

Completed
11 days until next milestone

First Posted

Study publicly available on registry

February 6, 2023

Completed
1.2 years until next milestone

Study Start

First participant enrolled

April 25, 2024

Completed
2.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 25, 2026

Expected
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

August 24, 2026

Last Updated

May 2, 2025

Status Verified

April 1, 2025

Enrollment Period

2.1 years

First QC Date

January 26, 2023

Last Update Submit

April 29, 2025

Conditions

Keywords

Peri-operative

Outcome Measures

Primary Outcomes (1)

  • 90 day complication rate

    Number of occurrences of complications at 90 days in patients in post-operative phase

    90 days

Secondary Outcomes (5)

  • 30 day complication rate

    30 days

  • Readmission rates

    90 days

  • Adherence to the intervention

    90 days

  • Changes in functional fitness as measured by step count

    Baseline, 90 days

  • QOL changes as measured by the Bladder Cancer Index and FACT-Bl-Cys Questionnaire measures

    Baseline, 90 days

Study Arms (2)

Intervention Arm

EXPERIMENTAL

Preop intervention Arm Referral to Perioperative Optimization of Senior Health (POSH) Program Remote patient monitoring device orientation, initial intake, and education UTSW ERAS protocol perioperatively Inpatient geriatrics co-management Monitored recovery Post-operative monitoring with Acticare for 90 days Post-op specialist continuity of care

Other: Preop Intervention and Monitored Recovery

Control Arm

ACTIVE COMPARATOR

Enhanced Recovery After Surgery Usual referral and recovery care as needed Standard follow-up protocol

Other: Usual Care

Interventions

Perioperative Optimization of Senior Health (POSH) Program; patient monitoring by device orientation, initial intake, education; ERAS protocol, inpatient geriatric co-management; and remote monitoring with Acticare device; post-op continuity of care

Also known as: Monitored recovery during post-operative phase
Intervention Arm

ERAS, Usual referral and recovery care, and Standard follow-up protocol

Control Arm

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adults equal to or more than 18 years old
  • Diagnosis of bladder cancer with plan to undergo radical cystectomy
  • Agrees to participate in study procedures

You may not qualify if:

  • Patients undergoing cystectomy for diagnosis other than bladder cancer
  • Do not provide informed consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Texas Southwestern Medical Center

Dallas, Texas, 75390-9164, United States

RECRUITING

MeSH Terms

Conditions

Urinary Bladder Neoplasms

Condition Hierarchy (Ancestors)

Urologic NeoplasmsUrogenital NeoplasmsNeoplasms by SiteNeoplasmsFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesUrinary Bladder DiseasesUrologic DiseasesMale Urogenital Diseases

Study Officials

  • Yair Lotan, MD

    University of Texas Southwestern Medical Center

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Model Details: It is a prospective randomized study that implements a multi-modal digitally based comprehensive health optimization program in the pre and post-operative setting in patients undergoing radical cystectomy for muscle invasive bladder cancer. Two patient groups will be enrolled and randomized where one group will go through the peri-operative optimization programs and the other group will receive the usual pre-op care followed by post-op care via standard follow-up protocol.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

January 26, 2023

First Posted

February 6, 2023

Study Start

April 25, 2024

Primary Completion (Estimated)

May 25, 2026

Study Completion (Estimated)

August 24, 2026

Last Updated

May 2, 2025

Record last verified: 2025-04

Data Sharing

IPD Sharing
Will not share

Locations